“…In addition, mammary tumor latency is increased in NOS2-knockout mice (43). Aberrant expression of NOS2 has been observed in human breast (12,13), colon (14,15), stomach (44,45), non-small cell lung (23), esophageal (46), and squamous cell head and neck cancer (47). In the two breast cancer studies, increased NOS2 correlated with tumor grade (12) and tumor angiogenesis and p53 protein accumulation (13).…”